Journal
CELL DEATH & DISEASE
Volume 5, Issue -, Pages -Publisher
SPRINGERNATURE
DOI: 10.1038/cddis.2014.504
Keywords
-
Categories
Funding
- National Taiwan University Cutting-Edge Steering Research Project [NTU-CESRP-103R7602C3]
- National Science Council of Taiwan [NSC 102-2628-B-002-041-MY3, NSC 102-2627-B-002-002, NSC 102-2311-B-010-004, MOST 103-2320-B-010-031-MY3]
Ask authors/readers for more resources
F1F0 ATP synthase is present in all organisms and is predominantly located on the inner membrane of mitochondria in eukaryotic cells. The present study demonstrated that ATP synthase and electron transport chain complexes were ectopically expressed on the surface of breast cancer cells and could serve as a potent anticancer target. We investigated the anticancer effects of the ATP synthase inhibitor citreoviridin on breast cancer cells through proteomic approaches and revealed that differentially expressed proteins in cell cycle regulation and in the unfolded protein response were functionally enriched. We showed that citreoviridin triggered PERK-mediated eIF2 alpha phosphorylation, which in turn attenuated general protein synthesis and led to cell cycle arrest in the G(0)/G(1) phase. We further showed that the combination of citreoviridin and the 26S proteasome inhibitor bortezomib could improve the anticancer activity by enhancing ER stress, by ameliorating citreoviridin-caused cyclin D-3 compensation, and by contributing to CDK1 deactivation and PCNA downregulation. More interestingly, the combined treatment triggered lethality through unusual non-apoptotic caspase-and autophagy-independent cell death with a cytoplasmic vacuolization phenotype. The results imply that by boosting ER stress, the combination of ATP synthase inhibitor citreoviridin and 26S proteasome inhibitor bortezomib could potentially be an effective therapeutic strategy against breast cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available